EMCURE PHARMS LTD FDA Approval ANDA 202693

ANDA 202693

EMCURE PHARMS LTD

FDA Drug Application

Application #202693

Application Sponsors

ANDA 202693EMCURE PHARMS LTD

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTIONEQ 500MG BASE/VIAL0ACETAZOLAMIDE SODIUMACETAZOLAMIDE SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2014-12-19

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

EMCURE PHARMS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202693
            [companyName] => EMCURE PHARMS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"ACETAZOLAMIDE SODIUM","activeIngredients":"ACETAZOLAMIDE SODIUM","strength":"EQ 500MG BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/19\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2014-12-19
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.